Home/Filings/4/0001209191-20-005787
4//SEC Filing

MAUNEY DAVID M MD 4

Accession 0001209191-20-005787

CIK 0001107421other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:51 PM ET

Size

7.3 KB

Accession

0001209191-20-005787

Insider Transaction Report

Form 4
Period: 2020-01-29
MAUNEY DAVID M MD
EVP and Chief Business Officer
Transactions
  • Award

    Common Stock

    2020-01-29+80,500275,778 total
  • Award

    Employee Stock Option (right to buy)

    2020-01-29+123,900123,900 total
    Exercise: $4.21Exp: 2030-01-29Common Stock (123,900 underlying)
Footnotes (2)
  • [F1]26,834 shares shall vest on 12/31/2020 and 26,833 shares shall vest on each of 12/31/2021 and 12/31/2022.
  • [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001305832

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:51 PM ET
Size
7.3 KB